Turning Data into Actionable
Decisions at the Point of Care
What Is Project DataPACT?
DataPACT turns the data already in your EHR into a monthly, provider-level care-gap report — so the right patient gets the right care, at the point of care.
Finds the gaps
Surfaces the patients who are overdue for guideline-indicated care and monitoring — before they fall through the cracks.
Four GI disease states
Delivered to your practice
A monthly report from the PPS team — baseline-to-current progress on every measure — emailed to your practice manager and lead physician. No new system, nothing to build.
Same chart. Same visit. The report tells you who needs what — you make the call at the point of care.
How the Data Gets to PPS
Every metric starts as discrete data you already capture in gGastro — it flows to PPS, and comes back as your report.
You document
Coded diagnoses, labs, scopes & procedures (CPT), meds and visits — captured as discrete fields in gGastro.
Flows to the EDW
That structured data feeds the PPS data warehouse (Snowflake) automatically — no extra step for you.
Scored vs KPIs
Every active patient measured against guideline KPIs — a global view of your population on the PPS dashboard.
Report + list
Care gaps and baseline-to-current progress emailed to your practice — and PPS can pull the exact patients.
It runs on discrete data. The structured, coded fields you already enter (not free-text notes) are what PPS can see — it's the documentation you already do, it just has to land in the right field to count.
The KPI Scoreboard
Every disease state is scored on the same four kinds of measures. Hover a category to see where it shows up.
IBDINFLAMMATORY BOWEL DISEASE
MASLD / MASHMETABOLIC LIVER DISEASE
CirrhosisCHRONIC LIVER DISEASE
EoEEOSINOPHILIC ESOPHAGITIS
From the PPS Quality of Care Initiatives program materials. One nuance to teach: Crohn's on mesalamine is the one measure where lower is better — it comes back in the DFW spotlight.
The Pathways Live Where You Work
The pathways live in the gGastro links menu — a ready reference, one click from any chart.
Click Refs — the globe button — from any chart to open the pathways menu.
Evidence-based pathways for all four disease states in one place — plus FIB-4 and the IBD guides.
A reference, not an integration — a “poster on the wall” in gGastro. It's there when you look; it won't prompt you on its own.
So knowing the KPIs matters — that's what today is for. And PPS can hand you the list of patients falling through the cracks.
One Pathway per Disease State
Each pathway turns a guideline into a decision you can make in the room. Click a card to see the full pathway.
IBD
- 5-ASA · advanced-therapy
- steroid guides · checklist
- + patient intake form
MASLD / MASH
- FIB-4 risk score
- elastography referral
- early fibrosis staging
Cirrhosis
- guideline surveillance
- lab monitoring
- co-management
EoE
- treatment initiation
- follow-up EGD (per KPI)
- histologic response
Same evidence base, four times over — so the pathway, not memory, drives the next order.
The IBD Pathway
DRIVES
WHERE TO FIND IT
HOW TO PRESENT IT
The MASLD / MASH Pathway
DRIVES
WHERE TO FIND IT
TRY IT LIVE — FIB-4, THE FIRST DECISION
The Cirrhosis Pathway
DRIVES
WHERE TO FIND IT
HOW TO PRESENT IT
The EoE Pathway
DRIVES
WHERE TO FIND IT
HOW TO PRESENT IT
How We Got Here
From a single-disease pilot to a multi-state program — in under two years.
The Pilot Proved It
…and it established the national baseline of care expectations for community-based GI practices — the yardstick every DataPACT report now uses.
The GIA Footprint
Place Your Bets
Before the reveal — which IBD measure do you think is lowest in DFW today? Show of hands for each.
Take the vote, then tap any card — or press → — to reveal.Fecal calprotectin — 27%. The cheapest, least-invasive monitoring tool is the one we order least. Press → for the full DFW picture.
The Opportunity in DFW — IBD
Our largest cluster. Here is what the DataPACT view shows for IBD in DFW right now.
CARE GAPS TO CLOSE TODAY — % COMPLETE
CCM enrollment — just 119 of 9,979Nearly untapped recurring, continuity care — and a standing reason to keep patients engaged.
Crohn's on oral mesalamine — 734 of 5,762A de-implementation target — 5-ASA isn't guideline-concordant for Crohn's. Step them onto the right therapy.
Source: PPS GI Data, July 2026 (DFW provider group). Bars show % of eligible patients meeting each measure — the remainder is the gap.
Ask PPS for the List
PPS Analytics can slice your population eight different ways — so the answer to “which patients?” is one ask away. You never build the list.
REAL PULLS PPS CAN HAND YOU
- Patients without a return appointment scheduled
- Age 45+ with no colonoscopy
- Patients with overdue recalls
- Lab trends — e.g. rising fecal calprotectin or CRP
- Medication trends — e.g. 2+ biologics on the med list
- Infusion patients to track
- Diagnostic & therapeutic candidates per disease state
- Research — clinical-trial candidates
The monthly report says how you're doing — these pulls tell you exactly who to call.
Where You Turn Data Into Care
The report lands with your manager — and PPS can pull the exact patients falling through the cracks. Three moves, all at the point of care.
Reengage
Bring lapsed patients back for the annual visit — and the overdue scope that comes with it.
Close the gaps
Order the calprotectin, CRP and labs. Schedule surveillance. Enroll eligible patients in CCM.
Right therapy
Get high-risk patients on advanced therapy. Step Crohn's off ineffective 5-ASA. The pathway guides the call.
captured services from reengagement in our first live division — visits, colonoscopies, EGDs and elastography — with no added physician work.
You Are Where Data Becomes Care
